ClinicalTrials.gg
CompletedNCT03424057Updated Feb 6, 2018

Asymmetric Primary Closure and Additional Skin Excision Technique.

An interventional study of Asymmetric Primary Closure and Additional Skin Excision Technique and Standard Karydakis technique. in Pilonidal Sinus, Pilonidal Disease of Natal Cleft and Surgical Technique, sponsored by Siverek Devlet Hastanesi. Completed. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-02-06.

Sponsored by Siverek Devlet Hastanesi · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Apr 2015, registered Jan 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The aim of this study was to reduce the residual dead-space volume with a modification following the standard Karydakis procedure.

Read the detailed description

All patients were operated in the jack-knife position under spinal anesthesia (SA). The gluteal parts of the patients were stretched in both directions with bandage and intergluteal cleft was opened. Methylen blue was administered from the sinus openings in the gluteal region. Then, total sinus excision was performed, including the entire sinus tracts by passing the skin, subcutaneous tissues up to the presacral fascia.

In patients operated with standard Karydakis procedure, a flap (Karydakis flap) extending along the incision was prepared, with the medial side of the wound to be 1 cm deep and 2-3 cm inward. The prepared flap was shifted to medial and sutured to the presacral fascia with 2/0 vicryl.

In patients who were operated with the Asymmetric Primary Closure with Skin Excision Technique, after the Karydakis flap was formed, 5-10 mm skin was excised along the incision from the side of the flap to reduce the volume of the dead-space laterally.

In both groups, subcutaneous tissue was approximated with 2/0 vicryl. The skin was sutured with mattress technique using 2/0 Prolene. No drains were used in patients from either group.

Patients were followed up for wound leakage, seroma and hematoma formation, skin dehiscence and recurrence.

02

Conditions studied

  • Pilonidal Sinus
  • Pilonidal Disease of Natal Cleft
  • Surgical Technique

Keywords

  • Karydakis modification
  • pilonidal sinus
  • seroma
03

In context

Pilonidal Sinus

109 studies on the registry are indexed under Pilonidal Sinus; 32 are open to participants now.

This study's enrollment of 100 is above the median of 80 across 72 interventional studies indexed under Pilonidal Sinus.

Browse Pilonidal Sinus studies →

Lead sponsor

Siverek Devlet Hastanesi is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients between age of 18-65 who had chronic pilonidal disease

Exclusion criteria

Exclusion Criteria:

  • Patients who did not accept the procedure
  • Patients had undergone previous pilonidal sinus surgery
  • Patientshad active infection
  • Patients who were not minimum of 18 years of age
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Group 1

    Group 1 were treated with the new technique (Asymmetric Primary Closure and Additional Skin Excision). In this new technique, following total sinus excision, the excision defect was closed with the standard Karydakis method, but an advancement tissue flap was performed using additional skin excision, in order to reduce the dead-space volume.

    Procedure: Asymmetric Primary Closure and Additional Skin Excision Technique

  • Active comparator
    Group 2

    Group 2 were treated with the standard Karydakis technique.

    Procedure: Standard Karydakis technique.

Interventions

  • ProcedureAsymmetric Primary Closure and Additional Skin Excision Technique

    In this new technique, following total sinus excision, the excision defect was closed with the standard Karydakis method, but an advancement tissue flap was performed using additional skin excision, in order to reduce the dead-space volume.

  • ProcedureStandard Karydakis technique.

    In this new technique, following total sinus excision, the excision defect was closed with the standard Karydakis method

06

What researchers measure

Primary outcomes

  1. Early postoperative complications.

    wound dehiscence, formation of seroma, hematoma, wound infection

    Time frame: 3 years

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — The study has been completed. The datas will be shared as an article

Supporting information: Study protocol, Statistical analysis plan, Clinical study report

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03424057
Lead sponsor
Siverek Devlet Hastanesi
Responsible party
Abdulcabbar Kartal (General surgeon, Siverek Devlet Hastanesi) — Principal investigator
First posted
Feb 6, 2018
Start date
Apr 15, 2015
Primary completion
Mar 25, 2016
Completion
Apr 15, 2016
Last update
Feb 6, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion